Condensed Statements of Operations - USD ($) |
3 Months Ended | |
|---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
| Operating Expenses | ||
| Research and development | $ 95,814 | $ 95,237 |
| Sales and marketing | 1,124 | 4,433 |
| General and administrative | 263,760 | 273,786 |
| Total operating expenses | 360,698 | 373,456 |
| Operating loss | (360,698) | (373,456) |
| Other Expenses | ||
| Loss on warrant exercise | 0 | (5,823) |
| Other expense | (380,926) | (199) |
| Total other expenses | (380,926) | (6,022) |
| Loss from operations before income taxes | (741,623) | (379,478) |
| Provision for income taxes | 0 | 0 |
| Net Loss | $ (741,623) | $ (379,478) |
| Net loss per share – basic and diluted | $ (1.03) | $ (.52) |
| Weighted average common shares – basic and diluted | 723,335 | 723,335 |